Nano Labs

Nano Labs Ltd (NA.US) traded lower during the regular session, falling 6.5% from the prior close of 1.840 to 1.720 by 12:54 PM ET, as early pre-market momentum faded despite strong earnings and mixed capital events. The stock reached an intraday high of 1.860 at 9:25 AM ET (pre-market, +1.1%) but reversed at the open and sank to a session low of 1.720 by 12:54 PM ET, forming a spike-and-drop pattern. Fundamental data showed Q4 2025 net profit surging 365.76% YoY to US$10.19 million, EPS of 0.4397 (up 207.05% YoY), and a net profit margin of 761.19%; however, operating loss widened 31.75% YoY to -US$2.61 million, highlighting structural profitability gaps. Valuation remains compressed with a PB of 0.37 and a total market cap of ~US$39.93 million. The stock sits 81.43% below its 52-week high of 9.26 and below both MA20 (1.881) and MA60 (2.237), with YTD decline of 47.56%. Pre-market news noted a 9% gain, and PiggyBank disclosed a recent US$100,000 OTC purchase of LAB. Conversely, Veea Inc.’s conversion of US$4.13 million in NLabs demand notes into Series A-1 preferred shares and warrants may fuel dilution worries.